Latest news
-
Regulating the Illusion of Intelligence in Ads
- CAP News
- 27 August 2026
-
Trust me, I'm a... compliant advertiser
- CAP News
- 13 August 2026
-
Keep your ads a cut above the rest: Advertising products and services for hair loss
- CAP News
- 09 July 2026
-
Scare with Care: Advertising Guidance on Phobias
- CAP News
- 11 June 2026
-
Giving mental health the airtime it deserves – Mental Health Awareness Week
- CAP News
- 14 May 2026
-
Not even Fenton would run away from our marketing tips
- CAP News
- 09 April 2026
Latest rulings
-
BioIdentical Hormone Therapy Ltd t/a BioID Health
- Upheld
- Social media (paid ad)
- 26 August 2026
Two paid-for Facebook ads for a hormone health consultant made misleading claims that they could provide more effective tests and services for low testosterone than GPs and were irresponsible by implying that GPs were insufficiently thorough.
-
Fenix Biomed BV
- Upheld
- Website (own site)
- 19 August 2026
A website for a human tissue donation service misleadingly implied they were based in the UK.
-
HealthTracker Apps t/a Blood Pressure Monitor App
- Upheld
- App (paid ad)
- 17 June 2026
Two paid-for in-app ads for a health app made medical claims for a product that wasn’t registered as a medical device and misleadingly implied that their app could monitor blood pressure and heart rate.
-
Hume Health LLC t/a HumeHealth
- Upheld
- Social media (paid ad)
- 17 June 2026
Three paid-for YouTube ads and a paid-for Facebook ad for Hume Health made medical claims for products that weren’t registered as medical devices, discouraged essential treatment for conditions for which medical supervision should be sought and exaggerated the capabilities of their products.

